GLP1R and multiple endocrine neoplasia type 2: GLP-1 RAs should be avoided in patients with familial history of multiple endocrine neoplasia type 2 (MEN2) or medullary thyroid carcinoma, and precaution should be taken in patients that had idiopathic pancreatitis.